CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Grant or award Director acquired 4,357 shares (grant or award)
- 4 Grant or award Director acquired 4,357 shares (grant or award)
- 4 Grant or award Director acquired 4,357 shares (grant or award)
- 4 Grant or award Director acquired 4,357 shares (grant or award)
- 4 Planned sale Director sold 2,000 shares at $80.88 ($161,760)
- 4 Planned sale SVP & CFO sold 3,312 shares at $80.00 ($264,960)
- 4 Open-market sale Director sold 13,973 shares at an average $80.66 ($1,127,120)
- 4 Open-market sale SVP, HEAD - ESTABLISHED BRANDS sold 459 shares at $79.21 ($36,357)
- 4 Open-market sale PRESIDENT & CEO sold 55,000 shares at $77.57 ($4,266,350)
- 4 Open-market sale SVP, GENERICS sold 2,772 shares at $79.50 ($220,374)
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 500 shares at $78.16 ($39,080)
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 500 shares at $77.95 ($38,975)
- 4 Open-market sale SVP, HEAD - ESTABLISHED BRANDS sold 4,772 shares at $74.91 ($357,471)
- 4 Planned sale HEAD OF RARE DISEASE sold 3,162 shares at $71.64 ($226,526)
- 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 500 shares at $72.62 ($36,310)
- 4 Planned sale HEAD OF RARE DISEASE sold 5,723 shares at an average $74.19 ($424,617)
- 4 Shares withheld for taxes PRESIDENT & CEO gave up 17,060 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, GENERICS gave up 3,314 shares (to pay taxes)
- 4 Planned sale SVP, CHIEF HR OFFICER sold 6,572 shares at an average $74.33 ($488,474)
- 4 Shares withheld for taxes SVP & CFO gave up 5,150 shares (to pay taxes)
Page 2 of 42 · 834 filings